330 related articles for article (PubMed ID: 29293399)
1. Challenges and new frontiers in analytical characterization of antibody-drug conjugates.
Wagh A; Song H; Zeng M; Tao L; Das TK
MAbs; 2018; 10(2):222-243. PubMed ID: 29293399
[TBL] [Abstract][Full Text] [Related]
2. A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates.
Wu G; Yu C; Yin S; Du J; Zhang Y; Fu Z; Wang L; Wang J
J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Jul; 1241():124167. PubMed ID: 38823148
[TBL] [Abstract][Full Text] [Related]
3. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.
Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580
[TBL] [Abstract][Full Text] [Related]
4. A size exclusion-reversed phase two dimensional-liquid chromatography methodology for stability and small molecule related species in antibody drug conjugates.
Li Y; Gu C; Gruenhagen J; Zhang K; Yehl P; Chetwyn NP; Medley CD
J Chromatogr A; 2015 May; 1393():81-8. PubMed ID: 25818558
[TBL] [Abstract][Full Text] [Related]
5. Antibody-drug conjugate characterization by chromatographic and electrophoretic techniques.
Chen T; Chen Y; Stella C; Medley CD; Gruenhagen JA; Zhang K
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():39-50. PubMed ID: 27451254
[TBL] [Abstract][Full Text] [Related]
6. An enzymatic deconjugation method for the analysis of small molecule active drugs on antibody-drug conjugates.
Li Y; Gu C; Gruenhagen J; Yehl P; Chetwyn NP; Medley CD
MAbs; 2016; 8(4):698-705. PubMed ID: 26891281
[TBL] [Abstract][Full Text] [Related]
7. Modeling of hydrophobic interaction chromatography for the separation of antibody-drug conjugates and its application towards quality by design.
Andris S; Hubbuch J
J Biotechnol; 2020 Jun; 317():48-58. PubMed ID: 32361022
[TBL] [Abstract][Full Text] [Related]
8. Analytical methods for physicochemical characterization of antibody drug conjugates.
Wakankar A; Chen Y; Gokarn Y; Jacobson FS
MAbs; 2011; 3(2):161-72. PubMed ID: 21441786
[TBL] [Abstract][Full Text] [Related]
9. Hydrophobic interaction chromatography (HIC) method development and characterization of resolved drug-load variants in site-specifically conjugated pyrrolobenzodiazepine dimer-based antibody drug conjugates (PBD-ADCs).
Janaratne T; Wang XC; Becker C; Zhao Y; Leanna R; Pritts W
J Pharm Biomed Anal; 2020 Feb; 179():113027. PubMed ID: 31830625
[TBL] [Abstract][Full Text] [Related]
10. Cutting-edge multi-level analytical and structural characterization of antibody-drug conjugates: present and future.
Beck A; D'Atri V; Ehkirch A; Fekete S; Hernandez-Alba O; Gahoual R; Leize-Wagner E; François Y; Guillarme D; Cianférani S
Expert Rev Proteomics; 2019 Apr; 16(4):337-362. PubMed ID: 30706723
[TBL] [Abstract][Full Text] [Related]
11. Real-Time Analysis on Drug-Antibody Ratio of Antibody-Drug Conjugates for Synthesis, Process Optimization, and Quality Control.
Tang Y; Tang F; Yang Y; Zhao L; Zhou H; Dong J; Huang W
Sci Rep; 2017 Aug; 7(1):7763. PubMed ID: 28798339
[TBL] [Abstract][Full Text] [Related]
12. Physical and Chemical Stability of Antibody Drug Conjugates: Current Status.
Ross PL; Wolfe JL
J Pharm Sci; 2016 Feb; 105(2):391-397. PubMed ID: 26869406
[TBL] [Abstract][Full Text] [Related]
13. Analytical techniques for the characterization of Antibody Drug Conjugates: Challenges and prospects.
Neupane R; Bergquist J
Eur J Mass Spectrom (Chichester); 2017 Dec; 23(6):417-426. PubMed ID: 29183195
[TBL] [Abstract][Full Text] [Related]
14. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
[TBL] [Abstract][Full Text] [Related]
15. Characterization of drug load variants in a thiol linked antibody-drug conjugate using multidimensional chromatography.
Gilroy JJ; Eakin CM
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():182-189. PubMed ID: 28622622
[TBL] [Abstract][Full Text] [Related]
16. Qualitative analysis of antibody-drug conjugates (ADCs): an experimental comparison of analytical techniques of cysteine-linked ADCs.
Källsten M; Hartmann R; Artemenko K; Lind SB; Lehmann F; Bergquist J
Analyst; 2018 Nov; 143(22):5487-5496. PubMed ID: 30289422
[TBL] [Abstract][Full Text] [Related]
17. Multi-attribute method based characterization of antibody drug conjugates (ADC) at the intact and subunit levels.
Martelet A; Garrigue V; Zhang Z; Genet B; Guttman A
J Pharm Biomed Anal; 2021 Jul; 201():114094. PubMed ID: 33957368
[TBL] [Abstract][Full Text] [Related]
18. Automated online deconjugation of antibody-drug conjugate for small molecule drug profiling.
Thomas R; Song D; Pourmohamad T; Kurita K; Chin S; Dai L; Goyon A; Medley CD; Gruenhagen JA; Chen T
J Chromatogr A; 2024 Jan; 1715():464575. PubMed ID: 38150875
[TBL] [Abstract][Full Text] [Related]
19. Physical Stability Studies of Antibody-Drug Conjugates (ADCs) Under Stressed Conditions.
Adem YT
Methods Mol Biol; 2020; 2078():301-311. PubMed ID: 31643066
[TBL] [Abstract][Full Text] [Related]
20. Rational design, biophysical and biological characterization of site-specific antibody-tubulysin conjugates with improved stability, efficacy and pharmacokinetics.
Thompson P; Fleming R; Bezabeh B; Huang F; Mao S; Chen C; Harper J; Zhong H; Gao X; Yu XQ; Hinrichs MJ; Reed M; Kamal A; Strout P; Cho S; Woods R; Hollingsworth RE; Dixit R; Wu H; Gao C; Dimasi N
J Control Release; 2016 Aug; 236():100-16. PubMed ID: 27327768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
